Pfizer has produced more than 70 million COVID-19 vaccine doses: CEO

NEW YORK (Reuters) – Chief Executive Albert Bourla reported Tuesday in a CNBC interview that Pfizer, Inc., and German partner BioNTech SE had developed over 70 million doses of their COVID-19 vaccine by the end of 2020.

"At the end of the last week of 2020, for example, we had already manufactured more than 70 million doses and we had released from there - because there's a quality control that you need to release - around 50 million doses. Then we manufactured more the first week of January," said Bourla.

"Right now I think we've released 33 million doses. And we have, let's say, half of what we have manufactured sitting on the shelves."

BioNTech reported on Monday, by introducing additional manufacturing lines and collecting more doses per vial, companies were increasing the 2021 delivery goal for their COVID-19 vaccine to 2 billion doses above 1.3 billion.

(Michael Erman's report)